GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (MEX:0QBO) » Definitions » Operating Cash Flow per Share

Coloplast AS (MEX:0QBO) Operating Cash Flow per Share : MXN31.14 (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Coloplast AS Operating Cash Flow per Share?

Coloplast AS's operating cash flow per share for the three months ended in Jun. 2024 was MXN17.51. Coloplast AS's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was MXN31.14.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Coloplast AS was -44.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -4.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Coloplast AS's Operating Cash Flow per Share or its related term are showing as below:

MEX:0QBO' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -4.2   Med: 9.4   Max: 28.1
Current: -4.2

During the past 13 years, Coloplast AS's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.10% per year. The lowest was -4.20% per year. And the median was 9.40% per year.

MEX:0QBO's 3-Year OCF Growth Rate is ranked worse than
59.86% of 695 companies
in the Medical Devices & Instruments industry
Industry Median: 3.2 vs MEX:0QBO: -4.20

Coloplast AS Operating Cash Flow per Share Historical Data

The historical data trend for Coloplast AS's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Operating Cash Flow per Share Chart

Coloplast AS Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.55 78.05 80.72 64.12 48.88

Coloplast AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.71 20.87 20.32 -27.56 17.51

Competitive Comparison of Coloplast AS's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Coloplast AS's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Price-to-Operating-Cash-Flow falls into.



Coloplast AS Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Coloplast AS's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (A: Sep. 2023 )=Cash Flow from Operations (A: Sep. 2023 )/Shares Outstanding (Diluted Average) (A: Sep. 2023 )
=10534.548/215.500
=48.88

Coloplast AS's Operating Cash Flow per Share for the quarter that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )=Cash Flow from Operations (Q: Jun. 2024 )/Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
=3936.909/224.800
=17.51

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN31.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast AS Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines